Trial Profile
A study of transdermal Diclofenac sodium (NAL1219) for the treatment of pain
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Aug 2016
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary)
- Indications Pain
- Focus Adverse reactions
- 16 Aug 2016 New trial record